MetLife (MET) Form 144 details planned sale of 335 common shares
Rhea-AI Filing Summary
MetLife-related accounts have filed a Form 144 to sell a small block of common stock. The notice covers a proposed sale of 335 shares of MetLife common stock through Wells Fargo, with an aggregate market value of 25,647.6, on the New York Stock Exchange on or about 12/01/2025. The issuer had 658,891,656 shares outstanding at the time referenced.
The seller acquired the 335 shares in a cash purchase from Goldman Sachs on 05/29/2015, with payment made on 06/03/2015. Over the past three months, several MetLife-related accounts, including Separate Account II, Separate Account SPI, Separate Account 149, the MetLife 401k Plan Trust-Large Cap Equity Index, and the MetLife 401k Plan Russell 1000 Value, sold additional blocks of MetLife common stock in multiple transactions, with gross proceeds for individual trades ranging from 1,345.72 to 27,282.69.
Positive
- None.
Negative
- None.
FAQ
What does MetLife (MET) disclose in this Form 144 notice?
The Form 144 notice discloses an intent to sell 335 shares of MetLife common stock through Wells Fargo, with an aggregate market value of 25,647.6, to be sold on or about 12/01/2025 on the New York Stock Exchange.
What representation does the seller make about MetLife (MET) in this Form 144?
The seller represents that they do not know any material adverse information regarding the current or prospective operations of MetLife that has not been publicly disclosed.